Alyeska Investment Group
SSAA

Alyeska Investment Group’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Alyeska Investment Group’s Portfolio SSAA Stock Details SSAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-162,501
Closed -$1.59M – 647
2022
Q2 		$1.59M Hold
162,501
– – 0.02% 428
2022
Q1 		$1.59M Hold
162,501
– – 0.02% 456
2021
Q4 		$1.58M Hold
162,501
– – 0.02% 475
2021
Q3 		$1.58M Hold
162,501
– – 0.02% 532
2021
Q2 		$1.58M Buy
+162,501
New +$1.59M 0.02% 542

Other funds holding SSAA

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Alyeska Investment Group's SSAA Position: Q3 2022 in Review

Alyeska Investment Group sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q3 2022, closing a stake of 162,501 shares — an estimated $1.59M sold.

Alyeska Investment Group first reported a position in SSAA in Q2 2021 and held it in 5 quarters. The position peaked at $1.59M in Q2 2022. 87 funds tracked by Wall St. Rank hold SSAA as of Q3 2022.

  • Alyeska Investment Group reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 162,501 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q3 2022, an estimated $1.59M.
  • Alyeska Investment Group first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 5 quarters.
  • Alyeska Investment Group's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $1.59M in Q2 2022.
  • 87 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.